Home > Financial Ratios > VAISHALI PHARMA

VAISHALI PHARMA
Core EBITDA Growth

    Back to All Ratios
VAISHALI PHARMA is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for VAISHALI PHARMA
Please provide your vote to see the results

VAISHALI PHARMA Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 2.11-68.1133.8294.6045.00

What is the latest Core EBITDA Growth ratio of VAISHALI PHARMA ?

The latest Core EBITDA Growth ratio of VAISHALI PHARMA is 2.11 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar20252.11
Mar2024-68.11
Mar202333.82
Mar202294.60
Mar202145.00

How is Core EBITDA Growth of VAISHALI PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2025 2.11
Positive
Mar2024 -68.11
Negative
Mar2023 33.82
-64.25
Mar2022 94.6
110.22
Mar2021 45 -

Other Financial Ratios of VAISHALI PHARMA


Compare Core EBITDA Growth ratio of peers of VAISHALI PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VAISHALI PHARMA ₹105.1 Cr -8.5% 40% -45.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹419,332.0 Cr 4.7% -0.3% -3.1% Stock Analytics
DIVIS LABORATORIES ₹170,800.0 Cr 2.3% 6.8% 9.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹141,578.0 Cr 2.5% -1.7% 26.5% Stock Analytics
DR REDDYS LABORATORIES ₹113,075.0 Cr 11.3% 7.6% 12.5% Stock Analytics
CIPLA ₹105,662.0 Cr 5.9% 7.3% -14.1% Stock Analytics


VAISHALI PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VAISHALI PHARMA

-8.5%

40%

-45.1%

SENSEX

-3%

5.8%

-3.4%


You may also like the below Video Courses